title: Surveillance of lymphatic filariasis 5 years after stopping mass drug administration in Menoufiya Governorate, Egypt.
abstract: The World Health Organization recommends that before lymphatic filariasis elimination in an area can be confirmed, an additional survey should be performed at least 5 years after stopping mass drug administration. The current study aimed to determine the status of lymphatic filariasis 5 years after cessation ofthe mass drug administration in 3 sentinel Egyptian villages in Menoufiya Governorate. The rapid immunochromatographic card test (ICT) and a new commercial antibody detection kit (CELISA®) were used. All 1321 primary-school children aged 6-7 years old were ICT negative but 27 children were antibody positive. All households surveyed in one village with the highest antibody prevalence were ICT negative, indicating an absence of lymphatic filariasis. The CELISA antibody kit needs more standardization and development to be useful under field conditions. We conclude that lymphatic filariasis is no longer a public health problem in these villages and other villages with similar epidemiological conditions.
authors: Department of Medical Parasitology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
authors: M A
authors: MA
authors: Moustafa
authors: Department of Medical Parasitology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
authors: H S
authors: HS
authors: Thabet
authors: Department of Medical Parasitology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
authors: G A
authors: GA
authors: Saad
authors: Department of Public Health, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
authors: M
authors: M
authors: El-Setouhy
authors: General Departmentfor Malaria, Filariasis and Leishmaniasis Control, Endemic Diseases Control Sector, Ministry of Health, Cairo, Egypt.
authors: M
authors: M
authors: Mehrez
authors: Department of Medical Parasitology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
authors: D M
authors: DM
authors: Hamdy
mesh_terms: D000871:Anthelmintics / Q000008:administration & dosage*; D002648:Child; D004534:Egypt / Q000453:epidemiology; D004605:Elephantiasis, Filarial / Q000453:epidemiology* / Q000517:prevention & control*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008297:Male; D011159:Population Surveillance; D015995:Prevalence; D013997:Time Factors
chemical_list: D000871:Anthelmintics